Strategy Into Impact – Kylie Wagner

In this episode of Spread Love in Organizations, Naji Gehchan sits down with Kylie Wagner, a senior commercial leader at Takeda with more than 20 years of experience across rare, specialty, and chronic care markets. Kylie shares the personal journey that brought her into healthcare, from her upbringing in the Midwest and her background as a competitive tennis player to the deeply personal experiences that shaped her commitment to improving patient outcomes. Her story is one of resilience, systems thinking, and purpose-driven leadership.

Together, Naji and Kylie explore what it truly takes to turn strategy into impact in healthcare and biotech. Kylie explains why even the strongest commercial strategies can fail when organizations do not execute effectively across complex cross-functional teams. She offers powerful insights into the importance of operations, decision-making, and building systems that allow teams to move faster so innovation can reach patients without delay.

The episode also dives into Kylie’s leadership philosophy, centered on trust, accountability, and clarity. She shares how leaders can create high-performing teams in times of uncertainty by listening deeply, empowering others, and embracing a digital-first mindset. This conversation is a thoughtful look at modern healthcare leadership and a powerful reminder that every decision made inside an organization ultimately shapes the patient experience.

"Patients cannot and should not wait."

MEET OUR GUEST Kylie Wagner, BioPharmaCommercial Executive.

Kylie Wagner is a commercial executive with more than 20 years of experience leading growth, portfolio performance, and launches across rare, specialty, and chronic markets.

She currently leads Marketing and Business Unit Customer Engagement at Takeda, where she is responsible for commercial strategy and P&L performance for a complex portfolio. Her work centers on translating scientific innovation into real-world adoption by aligning strategy, access, and customer engagement.

She builds organizations grounded in trust and accountability so teams can perform in uncertainty and turn strategy into consistent results.

In addition to her commercial leadership roles, she previously served as Chief of Staff to the U.S. Business Unit President, supporting enterprise strategy across the organization. She holds an Executive MBA from MIT Sloan School of Management.